Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

First Private Stem Cell Bank In Thailand Expects To Grow By Half In 2009

This article was originally published in PharmAsia News

Executive Summary

Thailand's first private umbilical cord stem cell bank expects an increase by as much as 50 percent this year. Thai StemLife, which reported a 25 percent increase in stem cells stored last year, anticipates even faster growth to be generated by an increase beyond the current 1 percent of new Thai parents who elect to have cord cells stored to provide the best source for later transplant for the child if needed. Thai StemLife COO Kostas Papadopoulos said the markets in neighboring Singapore and Malaysia already have reached 20 percent. But the potential also has attracted Thai competitors such as Cordlife, Cryoviva, Stem Cell for Life and Thai Health Baby. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069910

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel